Clinical Trial Update: PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating prevention of venous thromboembolism after acute ischemic stroke with enoxaparin (Lovenox) sponsored by Sanofi; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Venous Thromboembolism

Drugs mentioned

• Lovenox (enoxaparin)

Snippet

Sponsor: Sanofi | Conditions: Acute Ischemic Stroke | Phase 4 | Status: COMPLETED